Login / Signup

Reactivation of Varicella Zoster Virus after Vaccination for SARS-CoV-2.

Mina PsichogiouMichael SamarkosNikolaos MikosAngelos Hatzakis
Published in: Vaccines (2021)
Seven immunocompetent patients aged > 50 years old presented with herpes zoster (HZ) infection in a median of 9 days (range 7-20) after vaccination against SARS-CoV-2. The occurrence of HZ within the time window 1-21 days after vaccination defined for increased risk and the reported T cell-mediated immunity involvement suggest that COVID-19 vaccination is a probable cause of HZ. These cases support the importance of continuing assessment of vaccine safety during the ongoing massive vaccination for the COVID-19 pandemic and encourage reporting and communication of any vaccination-associated adverse event.
Keyphrases
  • sars cov
  • respiratory syndrome coronavirus
  • coronavirus disease
  • end stage renal disease
  • chronic kidney disease
  • ejection fraction
  • prognostic factors
  • adverse drug
  • clinical evaluation